Bioqual EBITDA Margin 2010-2025 | BIOQ
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Bioqual (BIOQ) over the last 10 years. The current EBITDA margin for Bioqual as of February 28, 2025 is .
| Bioqual EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2025-02-28 |
$0.05B |
$0.00B |
4.08% |
| 2024-11-30 |
$0.05B |
$0.00B |
2.00% |
| 2024-08-31 |
$0.06B |
$0.00B |
5.45% |
| 2024-05-31 |
$0.06B |
$0.01B |
10.17% |
| 2024-02-29 |
$0.06B |
$0.01B |
11.11% |
| 2023-11-30 |
$0.06B |
$0.01B |
8.06% |
| 2023-08-31 |
$0.06B |
$0.01B |
15.87% |
| 2023-05-31 |
$0.06B |
$0.01B |
11.11% |
| 2023-02-28 |
$0.07B |
$0.01B |
10.77% |
| 2022-11-30 |
$0.07B |
$0.01B |
14.71% |
| 2022-08-31 |
$0.07B |
$0.01B |
16.67% |
| 2022-05-31 |
$0.07B |
$0.01B |
21.54% |
| 2022-02-28 |
$0.06B |
$0.02B |
23.44% |
| 2021-11-30 |
$0.06B |
$0.02B |
25.00% |
| 2021-08-31 |
$0.06B |
$0.01B |
20.34% |
| 2021-05-31 |
$0.06B |
$0.01B |
22.03% |
| 2021-02-28 |
$0.06B |
$0.01B |
12.73% |
| 2020-11-30 |
$0.05B |
$0.01B |
12.96% |
| 2020-08-31 |
$0.05B |
$0.01B |
11.76% |
| 2020-05-31 |
$0.05B |
$0.01B |
10.87% |
| 2020-02-29 |
$0.05B |
$0.02B |
42.22% |
| 2019-11-30 |
$0.04B |
$0.02B |
41.86% |
| 2019-08-31 |
$0.04B |
$0.02B |
42.50% |
| 2019-05-31 |
$0.04B |
$0.02B |
60.00% |
| 2019-02-28 |
$0.04B |
$0.02B |
57.89% |
| 2018-11-30 |
$0.04B |
$0.03B |
80.56% |
| 2018-08-31 |
$0.04B |
$0.04B |
100.00% |
| 2018-05-31 |
$0.04B |
$0.04B |
100.00% |
| 2018-02-28 |
$0.04B |
$0.04B |
100.00% |
| 2017-11-30 |
$0.04B |
$0.04B |
100.00% |
| 2017-08-31 |
$0.04B |
$0.04B |
100.00% |
| 2017-05-31 |
$0.04B |
$0.04B |
100.00% |
| 2017-02-28 |
$0.04B |
$0.04B |
100.00% |
| 2016-11-30 |
$0.04B |
$0.04B |
100.00% |
| 2016-08-31 |
$0.04B |
$0.04B |
100.00% |
| 2016-05-31 |
$0.03B |
$0.03B |
100.00% |
| 2016-02-29 |
$0.03B |
$0.03B |
100.00% |
| 2015-11-30 |
$0.03B |
$0.03B |
100.00% |
| 2015-08-31 |
$0.03B |
$0.03B |
100.00% |
| 2015-05-31 |
$0.03B |
$0.03B |
100.00% |
| 2015-02-28 |
$0.03B |
$0.03B |
100.00% |
| 2014-08-31 |
$0.02B |
$0.02B |
100.00% |
| 2014-05-31 |
$0.02B |
$0.02B |
100.00% |
| 2013-11-30 |
$0.02B |
$0.02B |
100.00% |
| 2013-08-31 |
$0.02B |
$0.02B |
100.00% |
| 2013-05-31 |
$0.02B |
$0.02B |
100.00% |
| 2012-05-31 |
$0.02B |
$0.02B |
100.00% |
| 2012-02-29 |
$0.02B |
$0.02B |
100.00% |
| 2011-11-30 |
$0.02B |
$0.02B |
100.00% |
| 2011-08-31 |
$0.02B |
$0.02B |
100.00% |
| 2011-05-31 |
$0.02B |
$0.02B |
100.00% |
| 2011-02-28 |
$0.04B |
$0.04B |
100.00% |
| 2010-11-30 |
$0.04B |
$0.04B |
100.00% |
| 2010-08-31 |
$0.04B |
$0.04B |
100.00% |
| 2010-05-31 |
$0.04B |
$0.04B |
100.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.040B |
$0.059B |
|
BIOQUAL, Inc., formerly Diagnon Corporation, develops, produces and sells diagnostic test kits incorporating monoclonal antibodies to diagnose certain anemias, infections, and parasitic diseases.
|
